Substance / Medication

Alprenolol

Overview

Active Ingredient
alprenolol
RxNorm CUI
597

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Enantioselective determination of alprenolol in human plasma by liquid chromatography with tandem mass spectrometry using cellobiohydrolase chiral stationary phases.
Jiang Hongliang, Jiang Xiangyu, Ji Qin C · J Chromatogr B Analyt Technol Biomed Life Sci · 2008
PMID: 18691951Observational
Quantification of alprenolol and propranolol in human plasma using a two-dimensional liquid chromatography (2D-LC).
Gonçalves Virgínia M F, Rodrigues Patrícia, Ribeiro Cláudia et al. · J Pharm Biomed Anal · 2017
PMID: 28412606Other
Sweeping of alprenolol enantiomers with an organic solvent and sulfated β-cyclodextrin in capillary electrophoresis.
Rabanes Heide R, Quirino Joselito P · Electrophoresis · 2013
PMID: 23529954Other
Enantioselective biodegradation of pharmaceuticals, alprenolol and propranolol, by an activated sludge inoculum.
Ribeiro Ana R, Afonso Carlos M, Castro Paula M L et al. · Ecotoxicol Environ Saf · 2013
PMID: 23131609Other
Identification of Alprenolol Hydrochloride as an Anti-prion Compound Using Surface Plasmon Resonance Imaging.
Miyazaki Yukiko, Ishikawa Takeshi, Kamatari Yuji O et al. · Mol Neurobiol · 2019
PMID: 29704200Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Alprenolol (substance)
SNOMED CT
96294004
UMLS CUI
C0002334
RxNorm CUI
597

Clinical Data

This intervention maps to 4 entities in the Ltrl knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.